Liver enzymes and risk of diabetes and cardiovascular disease: Results of the Firenze Bagno a Ripoli (FIBAR) study
- 31 March 2008
- journal article
- Published by Elsevier BV in Metabolism
- Vol. 57 (3), 387-392
- https://doi.org/10.1016/j.metabol.2007.10.015
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention StudyDiabetes, 2007
- Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohortDiabetologia, 2006
- Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort studyBMJ, 2006
- Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study: The D.E.S.I.R. study (Data from an Epidemiological Study on the Insulin Resistance syndrome)Diabetes & Metabolism, 2005
- Five-year risk of developing clinical diabetes after first myocardial infarction; the FINAMI studyDiabetic Medicine, 2005
- Serum γ‐glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factorsDiabetic Medicine, 2005
- Elevated Serum GGT Concentrations Predict Reduced Insulin Sensitivity and Increased Intrahepatic LipidsHormone and Metabolic Research, 2005
- Silent non-alcoholic fatty liver disease—a clinical–histological studyJournal of Hepatology, 2004
- -Glutamyltransferase and risk of stroke: the EUROSTROKE projectJournal of Epidemiology and Community Health, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001